[
    [
        {
            "time": "2021-06-01",
            "orginal_text": "凯莱英(002821.SZ)拟发行H股并在香港联交所主板上市",
            "features": {
                "keywords": [
                    "凯莱英",
                    "H股",
                    "上市"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "凯莱英(002821.SZ)拟发行H股并在香港联交所主板上市",
            "scores": {
                "News_content": "凯莱英(002821.SZ)拟发行H股并在香港联交所主板上市",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-06-01",
            "orginal_text": "凯莱英(002821.SZ)拟补选李家聪为独立董事",
            "features": {
                "keywords": [
                    "凯莱英",
                    "独立董事",
                    "李家聪"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "凯莱英(002821.SZ)拟补选李家聪为独立董事",
            "scores": {
                "News_content": "凯莱英(002821.SZ)拟补选李家聪为独立董事",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 8,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06-01",
            "orginal_text": "凯莱英(002821.SZ)拟聘请安永会计师事务所为H股IPO申报会计师",
            "features": {
                "keywords": [
                    "凯莱英",
                    "安永",
                    "H股IPO"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "凯莱英(002821.SZ)拟聘请安永会计师事务所为H股IPO申报会计师",
            "scores": {
                "News_content": "凯莱英(002821.SZ)拟聘请安永会计师事务所为H股IPO申报会计师",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06-01",
            "orginal_text": "凯莱英：潘广成申请辞去公司独立董事等职务 董监高成员变化",
            "features": {
                "keywords": [
                    "凯莱英",
                    "潘广成",
                    "辞职"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "凯莱英：潘广成申请辞去公司独立董事等职务 董监高成员变化",
            "scores": {
                "News_content": "凯莱英：潘广成申请辞去公司独立董事等职务 董监高成员变化",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06-01",
            "orginal_text": "医疗健康产业2021年下半年投资策略：百花齐放 关注疫情后时代的医药强势复苏",
            "features": {
                "keywords": [
                    "医疗健康",
                    "投资策略",
                    "疫情后",
                    "复苏"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医疗健康产业2021年下半年投资策略：百花齐放 关注疫情后时代的医药强势复苏",
            "scores": {
                "News_content": "医疗健康产业2021年下半年投资策略：百花齐放 关注疫情后时代的医药强势复苏",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-06-01",
            "orginal_text": "券商5月金股组合\"战绩\"：开源证券14.13%夺冠 中泰最差",
            "features": {
                "keywords": [
                    "券商",
                    "金股组合",
                    "开源证券",
                    "中泰"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "券商5月金股组合\"战绩\"：开源证券14.13%夺冠 中泰最差",
            "scores": {
                "News_content": "券商5月金股组合\"战绩\"：开源证券14.13%夺冠 中泰最差",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-06-01",
            "orginal_text": "粤开医药行业周报|12省骨科创伤耗材带量采购启动，国药集团新冠疫苗Ⅲ期临床数据出炉",
            "features": {
                "keywords": [
                    "医药",
                    "带量采购",
                    "新冠疫苗",
                    "国药集团"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "粤开医药行业周报|12省骨科创伤耗材带量采购启动，国药集团新冠疫苗Ⅲ期临床数据出炉",
            "scores": {
                "News_content": "粤开医药行业周报|12省骨科创伤耗材带量采购启动，国药集团新冠疫苗Ⅲ期临床数据出炉",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-06-01",
            "orginal_text": "医药周报：骨修复材料市场增速近20% 人工材料为骨移植的新选择",
            "features": {
                "keywords": [
                    "医药",
                    "骨修复材料",
                    "人工材料"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医药周报：骨修复材料市场增速近20% 人工材料为骨移植的新选择",
            "scores": {
                "News_content": "医药周报：骨修复材料市场增速近20% 人工材料为骨移植的新选择",
                "Correlation": 4,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 4,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-06-01",
            "orginal_text": "医药生物行业跨市场周报：汇率影响有限 CXO行业景气度仍处于上行阶段",
            "features": {
                "keywords": [
                    "医药生物",
                    "CXO",
                    "景气度",
                    "汇率"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医药生物行业跨市场周报：汇率影响有限 CXO行业景气度仍处于上行阶段",
            "scores": {
                "News_content": "医药生物行业跨市场周报：汇率影响有限 CXO行业景气度仍处于上行阶段",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-06-01",
            "orginal_text": "八大券商主题策略：医药板块兼具科技加消费属性！未来3-5年是国产疫苗的黄金时代",
            "features": {
                "keywords": [
                    "医药",
                    "科技",
                    "消费",
                    "国产疫苗",
                    "黄金时代"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "八大券商主题策略：医药板块兼具科技加消费属性！未来3-5年是国产疫苗的黄金时代",
            "scores": {
                "News_content": "八大券商主题策略：医药板块兼具科技加消费属性！未来3-5年是国产疫苗的黄金时代",
                "Correlation": 6,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-06-01",
            "orginal_text": "医药行业周报：医药成“战略”投资 个股重视变化",
            "features": {
                "keywords": [
                    "医药",
                    "战略投资",
                    "个股变化"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医药行业周报：医药成“战略”投资 个股重视变化",
            "scores": {
                "News_content": "医药行业周报：医药成“战略”投资 个股重视变化",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-06-01",
            "orginal_text": "中信证券：医药投资进入了百花齐放的新时期",
            "features": {
                "keywords": [
                    "中信证券",
                    "医药投资",
                    "百花齐放"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "中信证券：医药投资进入了百花齐放的新时期",
            "scores": {
                "News_content": "中信证券：医药投资进入了百花齐放的新时期",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]